IVIG in APS pregnancy

Giuseppe Licata, Antonino Perino, Giovanni Triolo, Francesco Ciccia, Giovanni Triolo, Antonio Castelli, Marcello Cadelo

Risultato della ricerca: Articlepeer review

23 Citazioni (Scopus)

Abstract

For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as 'IVIG') has benefited patients with a variety of autoimmune disorders. A potential therapeutic role of IVIG in the prevention of thrombosis and of miscarriages in antiphospholipid syndrome (APS) has been postulated. Multicenter randomized controlled trials attempted to define the role of IVIG in preventing pregnancy complications in APS indicate that simple anticoagulation could not be completely satisfactory, and certain patient subgroups might take advantage of IVIG therapy alone or in combination with hepari
Lingua originaleEnglish
pagine (da-a)731-735
Numero di pagine5
RivistaLupus
Volume13
Stato di pubblicazionePublished - 2004

All Science Journal Classification (ASJC) codes

  • Rheumatology

Fingerprint Entra nei temi di ricerca di 'IVIG in APS pregnancy'. Insieme formano una fingerprint unica.

Cita questo